| Rite Aid Pharmacy #02210 | |
| 1400 Sulphur Spring Rd, Baltimore, Maryland 21227 | |
| (410) 737-9221 |
| Name | Rite Aid Pharmacy #02210 |
|---|---|
| Organization Name | Rite Aid Of Maryland Inc |
| Location | 1400 Sulphur Spring Rd, Baltimore, Maryland 21227 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 737-9221 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report.
Implantable Provider Group, a leading provider of implantable device management, announced today that it has secured an investment from Sequoia Capital. The funding will enable IPG to invest in future growth initiatives.
This Kaiser Health News story by Susan Jaffe, produced in partnership with The Washington Post, looks at an increasing use of hospital observation care for Medicare beneficiaries rather than admission as an inpatient.
Neuros Medical, Inc., a medical device company announced today they have received notification of award for $1.5 million from the U.S. Department of Defense. The Applied Research and Technology Development Award was provided by the Defense Medical Research and Development Program (DMRDP).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
› Verified 7 days ago
| NPI Number | 1518077288 |
| Organization Name | RITE AID OF MARYLAND INC |
| Doing Business As | RITE AID PHARMACY 02210 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1400 Sulphur Spring Road, Baltimore, MD 21227 |
| Phone Number | 410-737-9221 |
News Archive
Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report.
Implantable Provider Group, a leading provider of implantable device management, announced today that it has secured an investment from Sequoia Capital. The funding will enable IPG to invest in future growth initiatives.
This Kaiser Health News story by Susan Jaffe, produced in partnership with The Washington Post, looks at an increasing use of hospital observation care for Medicare beneficiaries rather than admission as an inpatient.
Neuros Medical, Inc., a medical device company announced today they have received notification of award for $1.5 million from the U.S. Department of Defense. The Applied Research and Technology Development Award was provided by the Defense Medical Research and Development Program (DMRDP).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
› Verified 7 days ago
| NPI Number | 1881118701 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID #18648 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1400 Sulphur Spring Rd, Baltimore, MD 21227 |
| Phone Number | 410-737-9221 |
News Archive
Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report.
Implantable Provider Group, a leading provider of implantable device management, announced today that it has secured an investment from Sequoia Capital. The funding will enable IPG to invest in future growth initiatives.
This Kaiser Health News story by Susan Jaffe, produced in partnership with The Washington Post, looks at an increasing use of hospital observation care for Medicare beneficiaries rather than admission as an inpatient.
Neuros Medical, Inc., a medical device company announced today they have received notification of award for $1.5 million from the U.S. Department of Defense. The Applied Research and Technology Development Award was provided by the Defense Medical Research and Development Program (DMRDP).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
› Verified 7 days ago
News Archive
Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report.
Implantable Provider Group, a leading provider of implantable device management, announced today that it has secured an investment from Sequoia Capital. The funding will enable IPG to invest in future growth initiatives.
This Kaiser Health News story by Susan Jaffe, produced in partnership with The Washington Post, looks at an increasing use of hospital observation care for Medicare beneficiaries rather than admission as an inpatient.
Neuros Medical, Inc., a medical device company announced today they have received notification of award for $1.5 million from the U.S. Department of Defense. The Applied Research and Technology Development Award was provided by the Defense Medical Research and Development Program (DMRDP).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
› Verified 7 days ago
Santa Monica Pharmacy And Medical S Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4300 Belair Rd, Baltimore, Maryland 21206 Phone: (410) 617-0116 | |
Rite Aid Pharmacy 00349 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4380 Park Heights Ave, Baltimore, Maryland 21215 Phone: (410) 664-8644 | |
Rite Aid Pharmacy 02214 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2855 Smith Ave, Baltimore, Maryland 21209 Phone: (410) 484-3200 | |
Rite Aid Pharmacy 00356 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3804 Liberty Heights Ave, Baltimore, Maryland 21215 Phone: (410) 367-5151 | |
Rite Aid Pharmacy 00385 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5804 Ritchie Hwy, Baltimore, Maryland 21225 Phone: (410) 789-3775 |